$JNJ Company News Ebola-nation travelers to U.
Post# of 102845
Posted On: 10/31/2014 11:55:30 AM
$JNJ Company News
Ebola-nation travelers to U.S. to be watched 21 days 3:04 p.m. Oct. 22, 2014 - Russ Britt
Johnson & Johnson to begin testing Ebola vaccine in January 9:14 a.m. Oct. 22, 2014 - Jonathan D. Rockoff
A possible new Ebola vaccine from Johnson&Johnson 4:32 a.m. Oct. 22, 2014 - MarketWatch
Fighting Ebola though investing: one firm’s approach 6:42 p.m. Oct. 21, 2014 - Wallace Witkowski
3 stocks Ken Fisher likes 11:09 a.m. Oct. 21, 2014 - Insider Monkey
Updates, advisories and surprises 5:31 p.m. Oct. 14, 2014 - MarketWatch
Delta, Citigroup gain; J.P. Morgan, Wells Fargo slide following results 10:58 a.m. Oct. 14, 2014 - Sue Chang
Newscast: Google launches same-day delivery 9:58 a.m. Oct. 14, 2014 - MarketWatch
All the reasons to sell this market are enough to draw a guy in 9:23 a.m. Oct. 14, 2014 - Shawn Langlois
J&J's earnings jump on higher drug sales 8:12 a.m. Oct. 14, 2014 - MarketWatch.com
Johnson & Johnson shares gain after profit beat, raised outlook 7:59 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson shares up 1% premarket after Q3 results 7:50 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson ups 2014 EPS outlook to $5.92-$5.97 from $5.85-$5.92 7:50 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 net EPS $1.66 vs. $1.04 a year ago 7:49 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 sales of $18.5 bln vs. FactSet consensus $18.44 bln 7:48 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 sales up 5.1% from last year to $18.5 bln 7:47 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 adj. EPS $1.50 vs. FactSet consensus $1.45 7:47 a.m. Oct. 14, 2014 - Tomi Kilgore
What to expect from Johnson & Johnson’s earnings 7:09 a.m. Oct. 14, 2014 - Tomi Kilgore
The market in a minute: Schizophrenic action 12:40 p.m. Oct. 13, 2014 - The Trading Deck
Earnings under pressure from stronger U.S. dollar 5:30 a.m. Oct. 12, 2014 - Wallace Witkowski
Stock Market News for October 31, 2014 - Market News 10:10 a.m. Today - Zacks.com
Retirees Feeling Anxious? Take 3 Of These Pharmaceuticals, Then Call Me In The Morning 9:00 p.m. Oct. 30, 2014 - Seeking Alpha
Protecting Your Portfolio And Selling For Capital Gains: Is It Worth It For Dividend Growth Investors? 7:53 p.m. Oct. 30, 2014 - Seeking Alpha
The New Nifty Fifty, Part 3: Dividend Growth Ideas And Valuations 5:32 p.m. Oct. 30, 2014 - Seeking Alpha
10-Q: JOHNSON & JOHNSON 5:11 p.m. Oct. 30, 2014 - Edgar Online - (EDG = 10Q, 10K)
Did Wright Medical Make The Right Move? 1:12 p.m. Oct. 30, 2014 - Seeking Alpha
Big Pharma Solid Q3 Earnings Put These ETFs in Focus - ETF News And Commentary 1:00 p.m. Oct. 30, 2014 - Zacks.com
Dow Jones (DJIA) Today: Johnson & Johnson (JNJ) Higher 12:00 p.m. Oct. 30, 2014 - TheStreet.com
Johnson & Johnson Fairly Valued - I Will Bet on It 11:26 a.m. Oct. 30, 2014 - GuruFocus.com
Lakeland (LAKE) Stock Soars 30% on Hazmat Suit Sales, Ebola Panic - Stocks in the News 11:16 a.m. Oct. 30, 2014 - Zacks.com
3 Stocks Reiterated As A Buy: MDLZ, V, JNJ 11:14 a.m. Oct. 30, 2014 - TheStreet.com
Novartis: Continued Operating Strength, Shares Fairly Valued 4:31 p.m. Oct. 29, 2014 - Seeking Alpha
Dow Jones (DJIA) Today: Johnson & Johnson (JNJ) Leads The Day Higher, Visa (V) Lags 4:30 p.m. Oct. 29, 2014 - TheStreet.com
Vertex Pharmaceuticals Posts Narrower-than-Expected Loss - Analyst Blog 1:00 p.m. Oct. 29, 2014 - Zacks.com
3 Health Care Picks To Beat Earnings - Earnings ESP 12:09 p.m. Oct. 29, 2014 - Zacks.com
Top- And Bottom-Performing Dividend Stocks Through September 8:37 p.m. Oct. 28, 2014 - Seeking Alpha
U.S. Earnings Reassure Investors but Growth Lags 7:19 p.m. Oct. 28, 2014 - The Wall Street Journal Interactive Edition
Bet The Farm On Gilead 2:45 p.m. Oct. 28, 2014 - Seeking Alpha
Video: Facebook, Gilead Post Earnings After The Close 1:00 p.m. Oct. 28, 2014 - Investors Business Daily
Receptos Soars After Lead Drug Racks Up Another Win 10:46 a.m. Oct. 28, 2014 - Investors Business Daily
Coronary Stents Market (Bare Metal Stents, Drug Eluting Stents and Bio-absorbable Stents) - Global Industry Analysis, Size, Share, Pipeline Overview, Growth, Trends and Forecast, 2013 - 2019 8:00 p.m. Oct. 30, 2014 - PR Newswire - PRF
In 2023, Medivation/Astellas Pharma's Xtandi Will Be the Top-Selling Agent in the Prostate Cancer Market Across the United States, Europe, and Japan 1:00 p.m. Oct. 30, 2014 - PR Newswire - PRF
Financial Results, Program Expansion, Product Launch, and Share Dealings - Research Reports on Merck, Johnson & Johnson, Amgen, Medtronic and Shire 9:15 a.m. Oct. 30, 2014 - PR Newswire - PRF
Johnson & Johnson Diabetes Solutions Companies Join The Joslin Institute for Technology Translation (JITT) As Founding Members 9:00 a.m. Oct. 30, 2014 - BusinessWire - BZX
Capital Increase in Bavarian Nordic A/S as a Result of Completion of a Direct Placement to Johnson & Johnson Development Corporation 5:15 a.m. Oct. 29, 2014 - Thomson Reuters ONE
Johnson & Johnson Innovation Launches Asia Pacific Innovation Center and Announces New Alliances 4:00 p.m. Oct. 28, 2014 - PR Newswire - PRF
GTCR Announces Sale of Devicor Medical Products 7:32 a.m. Oct. 28, 2014 - BusinessWire - BZX
Global and China Monoclonal Antibody Industry Report, 2014-2019 9:26 p.m. Oct. 27, 2014 - PR Newswire - PRF
Axxess Pharma Retains Natural Products Consulting Institute "NPCI" for Health Canada Approval of TapouT High Potency Omega-3 Fish Oil and TapouT Turbo Blend Protein Powder 8:02 a.m. Oct. 23, 2014 - Marketwired
Bavarian Nordic Announces Expanded Collaboration with Janssen on MVA-BN(R) for Additional Infectious Disease Targets 5:47 p.m. Oct. 22, 2014 - Thomson Reuters ONE
TransPerfect Princeton Opens for Business 9:45 a.m. Oct. 22, 2014 - BusinessWire - BZX
Bavarian Nordic Enters Licensing and Supply Agreement with Janssen on MVA-BN(R) Ebola Vaccine 2:06 a.m. Oct. 22, 2014 - GlobeNewswire
Johnson & Johnson Announces Major Commitment to Speed Ebola Vaccine Development and Significantly Expand Production 2:02 a.m. Oct. 22, 2014 - PR Newswire - PRF
Bavarian Nordic Announces Additional Details Concerning the Issue of Shares to Johnson & Johnson Development Corporation 1:56 a.m. Oct. 22, 2014 - Thomson Reuters ONE
Bavarian Nordic Enters Licensing and Supply Agreement with Janssen on MVA-BN(R) Ebola Vaccine 1:56 a.m. Oct. 22, 2014 - Thomson Reuters ONE
Vaccines, Medical Oxygen, and Helping the Ebola Crisis 1:47 p.m. Oct. 21, 2014 - ACCESSWIRE
Merger Deal Updates, Dividend, Dispute Settlement, Regulatory Application Submission, and Preliminary Results - Research Reports on Shire, Johnson & Johnson, Merck, Amgen and HCA 9:00 a.m. Oct. 21, 2014 - PR Newswire - PRF
Post-Earnings Insight - Johnson and Johnson 9:05 a.m. Oct. 16, 2014 - PR Newswire - PRF
Tetra Discovery Partners Announces Additional Financing and Formation of Scientific Advisory Board 8:03 a.m. Oct. 16, 2014 - PR Newswire - PRF
Aduro Expands Collaboration with Johnson & Johnson Innovation and Janssen for Lung Cancer Immunotherapies 8:01 a.m. Oct. 16, 2014 - BusinessWire - BZX
Ebola-nation travelers to U.S. to be watched 21 days 3:04 p.m. Oct. 22, 2014 - Russ Britt
Johnson & Johnson to begin testing Ebola vaccine in January 9:14 a.m. Oct. 22, 2014 - Jonathan D. Rockoff
A possible new Ebola vaccine from Johnson&Johnson 4:32 a.m. Oct. 22, 2014 - MarketWatch
Fighting Ebola though investing: one firm’s approach 6:42 p.m. Oct. 21, 2014 - Wallace Witkowski
3 stocks Ken Fisher likes 11:09 a.m. Oct. 21, 2014 - Insider Monkey
Updates, advisories and surprises 5:31 p.m. Oct. 14, 2014 - MarketWatch
Delta, Citigroup gain; J.P. Morgan, Wells Fargo slide following results 10:58 a.m. Oct. 14, 2014 - Sue Chang
Newscast: Google launches same-day delivery 9:58 a.m. Oct. 14, 2014 - MarketWatch
All the reasons to sell this market are enough to draw a guy in 9:23 a.m. Oct. 14, 2014 - Shawn Langlois
J&J's earnings jump on higher drug sales 8:12 a.m. Oct. 14, 2014 - MarketWatch.com
Johnson & Johnson shares gain after profit beat, raised outlook 7:59 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson shares up 1% premarket after Q3 results 7:50 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson ups 2014 EPS outlook to $5.92-$5.97 from $5.85-$5.92 7:50 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 net EPS $1.66 vs. $1.04 a year ago 7:49 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 sales of $18.5 bln vs. FactSet consensus $18.44 bln 7:48 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 sales up 5.1% from last year to $18.5 bln 7:47 a.m. Oct. 14, 2014 - Tomi Kilgore
Johnson & Johnson Q3 adj. EPS $1.50 vs. FactSet consensus $1.45 7:47 a.m. Oct. 14, 2014 - Tomi Kilgore
What to expect from Johnson & Johnson’s earnings 7:09 a.m. Oct. 14, 2014 - Tomi Kilgore
The market in a minute: Schizophrenic action 12:40 p.m. Oct. 13, 2014 - The Trading Deck
Earnings under pressure from stronger U.S. dollar 5:30 a.m. Oct. 12, 2014 - Wallace Witkowski
Stock Market News for October 31, 2014 - Market News 10:10 a.m. Today - Zacks.com
Retirees Feeling Anxious? Take 3 Of These Pharmaceuticals, Then Call Me In The Morning 9:00 p.m. Oct. 30, 2014 - Seeking Alpha
Protecting Your Portfolio And Selling For Capital Gains: Is It Worth It For Dividend Growth Investors? 7:53 p.m. Oct. 30, 2014 - Seeking Alpha
The New Nifty Fifty, Part 3: Dividend Growth Ideas And Valuations 5:32 p.m. Oct. 30, 2014 - Seeking Alpha
10-Q: JOHNSON & JOHNSON 5:11 p.m. Oct. 30, 2014 - Edgar Online - (EDG = 10Q, 10K)
Did Wright Medical Make The Right Move? 1:12 p.m. Oct. 30, 2014 - Seeking Alpha
Big Pharma Solid Q3 Earnings Put These ETFs in Focus - ETF News And Commentary 1:00 p.m. Oct. 30, 2014 - Zacks.com
Dow Jones (DJIA) Today: Johnson & Johnson (JNJ) Higher 12:00 p.m. Oct. 30, 2014 - TheStreet.com
Johnson & Johnson Fairly Valued - I Will Bet on It 11:26 a.m. Oct. 30, 2014 - GuruFocus.com
Lakeland (LAKE) Stock Soars 30% on Hazmat Suit Sales, Ebola Panic - Stocks in the News 11:16 a.m. Oct. 30, 2014 - Zacks.com
3 Stocks Reiterated As A Buy: MDLZ, V, JNJ 11:14 a.m. Oct. 30, 2014 - TheStreet.com
Novartis: Continued Operating Strength, Shares Fairly Valued 4:31 p.m. Oct. 29, 2014 - Seeking Alpha
Dow Jones (DJIA) Today: Johnson & Johnson (JNJ) Leads The Day Higher, Visa (V) Lags 4:30 p.m. Oct. 29, 2014 - TheStreet.com
Vertex Pharmaceuticals Posts Narrower-than-Expected Loss - Analyst Blog 1:00 p.m. Oct. 29, 2014 - Zacks.com
3 Health Care Picks To Beat Earnings - Earnings ESP 12:09 p.m. Oct. 29, 2014 - Zacks.com
Top- And Bottom-Performing Dividend Stocks Through September 8:37 p.m. Oct. 28, 2014 - Seeking Alpha
U.S. Earnings Reassure Investors but Growth Lags 7:19 p.m. Oct. 28, 2014 - The Wall Street Journal Interactive Edition
Bet The Farm On Gilead 2:45 p.m. Oct. 28, 2014 - Seeking Alpha
Video: Facebook, Gilead Post Earnings After The Close 1:00 p.m. Oct. 28, 2014 - Investors Business Daily
Receptos Soars After Lead Drug Racks Up Another Win 10:46 a.m. Oct. 28, 2014 - Investors Business Daily
Coronary Stents Market (Bare Metal Stents, Drug Eluting Stents and Bio-absorbable Stents) - Global Industry Analysis, Size, Share, Pipeline Overview, Growth, Trends and Forecast, 2013 - 2019 8:00 p.m. Oct. 30, 2014 - PR Newswire - PRF
In 2023, Medivation/Astellas Pharma's Xtandi Will Be the Top-Selling Agent in the Prostate Cancer Market Across the United States, Europe, and Japan 1:00 p.m. Oct. 30, 2014 - PR Newswire - PRF
Financial Results, Program Expansion, Product Launch, and Share Dealings - Research Reports on Merck, Johnson & Johnson, Amgen, Medtronic and Shire 9:15 a.m. Oct. 30, 2014 - PR Newswire - PRF
Johnson & Johnson Diabetes Solutions Companies Join The Joslin Institute for Technology Translation (JITT) As Founding Members 9:00 a.m. Oct. 30, 2014 - BusinessWire - BZX
Capital Increase in Bavarian Nordic A/S as a Result of Completion of a Direct Placement to Johnson & Johnson Development Corporation 5:15 a.m. Oct. 29, 2014 - Thomson Reuters ONE
Johnson & Johnson Innovation Launches Asia Pacific Innovation Center and Announces New Alliances 4:00 p.m. Oct. 28, 2014 - PR Newswire - PRF
GTCR Announces Sale of Devicor Medical Products 7:32 a.m. Oct. 28, 2014 - BusinessWire - BZX
Global and China Monoclonal Antibody Industry Report, 2014-2019 9:26 p.m. Oct. 27, 2014 - PR Newswire - PRF
Axxess Pharma Retains Natural Products Consulting Institute "NPCI" for Health Canada Approval of TapouT High Potency Omega-3 Fish Oil and TapouT Turbo Blend Protein Powder 8:02 a.m. Oct. 23, 2014 - Marketwired
Bavarian Nordic Announces Expanded Collaboration with Janssen on MVA-BN(R) for Additional Infectious Disease Targets 5:47 p.m. Oct. 22, 2014 - Thomson Reuters ONE
TransPerfect Princeton Opens for Business 9:45 a.m. Oct. 22, 2014 - BusinessWire - BZX
Bavarian Nordic Enters Licensing and Supply Agreement with Janssen on MVA-BN(R) Ebola Vaccine 2:06 a.m. Oct. 22, 2014 - GlobeNewswire
Johnson & Johnson Announces Major Commitment to Speed Ebola Vaccine Development and Significantly Expand Production 2:02 a.m. Oct. 22, 2014 - PR Newswire - PRF
Bavarian Nordic Announces Additional Details Concerning the Issue of Shares to Johnson & Johnson Development Corporation 1:56 a.m. Oct. 22, 2014 - Thomson Reuters ONE
Bavarian Nordic Enters Licensing and Supply Agreement with Janssen on MVA-BN(R) Ebola Vaccine 1:56 a.m. Oct. 22, 2014 - Thomson Reuters ONE
Vaccines, Medical Oxygen, and Helping the Ebola Crisis 1:47 p.m. Oct. 21, 2014 - ACCESSWIRE
Merger Deal Updates, Dividend, Dispute Settlement, Regulatory Application Submission, and Preliminary Results - Research Reports on Shire, Johnson & Johnson, Merck, Amgen and HCA 9:00 a.m. Oct. 21, 2014 - PR Newswire - PRF
Post-Earnings Insight - Johnson and Johnson 9:05 a.m. Oct. 16, 2014 - PR Newswire - PRF
Tetra Discovery Partners Announces Additional Financing and Formation of Scientific Advisory Board 8:03 a.m. Oct. 16, 2014 - PR Newswire - PRF
Aduro Expands Collaboration with Johnson & Johnson Innovation and Janssen for Lung Cancer Immunotherapies 8:01 a.m. Oct. 16, 2014 - BusinessWire - BZX
(0)
(0)